| GeneLibs

题目:: Genetically engineered immune privileged Sertoli cells: A new road to cell based gene therapy.
作者:: Kaur(Gurvinder),Long(Charles R),Dufour(Jannette M)
状态:: 发布时间2012-05-03 , 更新时间 2016-10-19
期刊:: Spermatogenesis
摘要:: Sertoli cells are immune privileged cells, important for controlling the immune response to male germ cells as well as maintaining the tolerogenic environment in the testis. Additionally, ectopic Sertoli cells have been shown to survive and protect co-grafted cells when transplanted across immunological barriers. The survival of ectopic Sertoli cells has led to the idea that they could be used in cell based gene therapy. In this review, we provide a brief overview of testis immune privilege and Sertoli cell transplantation, factors contributing to Sertoli cell immune privilege, the challenges faced by viral vector gene therapy, the use of immune privileged cells in cell based gene therapy and describe several recent studies on the use of genetically engineered Sertoli cells to provide continuous delivery of therapeutic proteins.
语言:: eng
DOI:

文献库文献相关信息